Liver International

Papers
(The H4-Index of Liver International is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Frequency of the PNPLA3 rs738409 polymorphism and other genetic loci for liver disease in a Guatemalan adult population186
Navigating portal hypertension: Unlocking safe passage to healthy pregnancy in EHPVO157
Long‐term outcomes after liver transplantation for ACLF – Don’t forget quality of life!93
Author's reply: The relationship between systemic inflammation and liver fibrogenesis in patients with cirrhosis92
Different methodologies of protein induced by vitamin K absence or antagonist II in patients without hepatocellular carcinoma89
Letter to the Editor regarding “Long‐term exposure to air pollution and incident non‐alcoholic fatty liver disease and cirrhosis”81
MNS1 promotes hepatocarcinogenesis and metastasis via activating PI3K/AKT by translocating β‐catenin and predicts poor prognosis79
Endogenous Sex Hormones and Significant Hepatic Fibrosis in US Adults75
Liver Disease Complicating Familial Mediterranean Fever: A Study on 66 Patients Out of 533 Adult From the JIR Cohort63
Liver Injury due to Intravenous Methylprednisolone in the Drug‐Induced Liver Injury Network62
Acute and acute‐on‐chronic liver failure: Pathogenesis, management and perspectives62
Genetic Variants of GBP4: Reduced Risks for Drug‐Induced Acute Liver Failure in Non‐Finnish European Population61
The Potential and Challenges of Autophagy in the Treatment of Liver Fibrosis61
No impact of COVID‐19 epidemic on decompensation of alcoholic liver disease: Results from a single centre in Milan59
DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti‐DKK1 therapeutic DKN‐0159
High disease burden and healthcare resource usage in patients with acute porphyria—A population‐based analysis54
Intraindividual comparison of prognostic imaging features of HCCs between MRIs with extracellular and hepatobiliary contrast agents53
AI‐based digital pathology provides newer insights into lifestyle intervention‐induced fibrosis regression in MASLD: An exploratory study53
Cover Image51
High end‐of‐treatment hepatitis B core‐related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy51
Reply to: “Fatty liver disease at the basis of cardiac remodelling and increased heart rate: Insights from the UK Biobank”50
Issue Information46
45
Fatty liver disease at the basis of cardiac remodelling and increased heart rate: Insights from the UK Biobank45
Effect of statins on the recurrence of hepatocellular carcinoma after liver transplantation: An illusion revealed by exposure density sampling44
Prevalence of advanced hepatic fibrosis and comorbidity in metabolic dysfunction‐associated fatty liver disease in Korea43
43
42
Issue Information41
Tolvaptan for difficult‐ to ‐treat ascites: Difficulties in opening doors for GWAS application41
Is fresh frozen plasma transfusion associated with outcomes in acute variceal bleeding?41
Issue Information41
Improving the accuracy of outcome prediction for hepatocellular carcinoma: Asia strategies40
How to get away with liver innate immunity? A viruses’ tale39
MR elastography to predict haemodynamic response to beta‐blockers—The story is still incomplete39
Unlocking liver health: Can tackling myosteatosis spark remission in metabolic dysfunction‐associated steatotic liver disease?38
HBV cure—The light at the end of the tunnel?37
37
Prognosis algorithms for acute decompensation of cirrhosis and ACLF37
Improving prediction of hepatocellular carcinoma in chronic hepatitis B by machine learning: Productive relationship of medicine with computer science37
Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology37
0.16276693344116